Artificial Intelligence technology is being developed and combined with our present technologies to create new unique possibilities for image processing and future innovative products.
We are continuing to enhance our tools for remote communication and customer support. These tools and communication formats will also be valuable post-pandemic. The present year will hopefully offer a gradual return to an environment where both digital and physical meetings and interactions are normal options. We truly appreciate all the joint endeavors to prevent spread of the virus, and are determined to further our progress in business projects. We greatly look forward to meet our customers and partners face to face as soon as possible.
STOCKHOLM – July 26, 2021 – Olof Sandén, Chairman of the Board of ContextVision, has on July 6, 2021 purchased 500 shares in ContextVision AB at an...
ContextVision announces agreement with two renowned US cancer centers for clinical evaluation of INIFY® ProstateSTOCKHOLM – July 6, 2021 – ContextVision, a medical technology software company specializing in image processing, image analysis and decision suppo...
ContextVision announces signed contract with Vall d’Hebron for clinical evaluation of INIFY® Prostate ScreeningINIFY® Prostate Screening is a powerful AI-based software that predicts, outlines and quantifies suspicious cancerous areas in a series of prostate...
ContextVision’s primary strength is our motivated and talented workforce. We want to add to that strength by employing talented individuals who are willing to work for a leading company dedicated to medical imaging and innovative technologies. In return, we will encourage you to develop and manage your career with us, in a stimulating and international environment.
Welcome to ContextVision!